Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
3.3%
% of VHT's 417 holdings also in OZEM
54.2%
% of OZEM's 25 holdings also in VHT
Overlap by Weight
Sector Drift (VHT minus OZEM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.0% | 17.7% | 11.0% |
|
AMGEN INC | 2.7% | 4.7% | 2.7% |
|
PFIZER INC | 2.4% | 3.7% | 2.4% |
|
GILEAD SCIENCES INC | 2.3% | 2.7% | 2.3% |
|
REGENERON PHARMACEUTICALS | 1.1% | 2.4% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
VHT Overweight Relative to OZEM
|
UNITEDHEALTH GROUP INC | 7.9% |
|
ABBVIE INC | 5.4% |
|
JOHNSON & JOHNSON | 4.9% |
|
ABBOTT LABORATORIES | 3.8% |
|
MERCK & CO. INC. | 3.6% |
|
THERMO FISHER SCIENTIFIC INC | 3.2% |
|
INTUITIVE SURGICAL INC | 2.9% |
|
BOSTON SCIENTIFIC CORP | 2.4% |
|
DANAHER CORP | 2.2% |
|
VERTEX PHARMACEUTICALS INC | 2.1% |
VHT Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -12.7% |
|
ELI LILLY & CO | -6.7% |
 |
ROCHE HOLDING LTD | -6.5% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.2% |
 |
INNOVENT BIOLOGICS, INC. | -4.9% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.8% |
|
ZEALAND PHARMA A/S | -3.9% |
 |
HANMI PHARM CO LTD | -2.9% |
 |
THE UNITED LABORATORIES INTE | -2.7% |
|
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -2.4% |